- 24/7 Wall St.•yesterday
Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research firm is seeing one of these companies in a positive light.
AstraZeneca plc (ADR) (NYSE: AZN ) shares are currently trading at a discount to S&P 500 pharma companies. Argus’ John Eade believes the discount is too steep given the company’s pipeline potential. Eade ...
AstraZeneca PLC (AZN)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||33.22 x 1600|
|Ask||33.23 x 3300|
|Day's Range||33.07 - 33.31|
|52wk Range||26.97 - 35.04|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||37.91|
|Avg Vol (3m)||6,104,518|
|Dividend & Yield||0.90 (2.72%)|